Site Search
Search Results
Let's Screen NY Campaign Homepage
... they are found, they will be at more advanced stages. Indeed, cancer-related mortality rates have also increased during the pandemic. While health care professionals across the state are working overtime to get people back to regular screening, we need policymakers to do their part too. What is the Let's Screen NY Campaign? Let’s #ScreenNY is a statewide coalition of patient advocacy groups, health systems, community organizations, individuals, policymakers, and others who are committed to helping ensure that all New Yorkers get back to ...
Policy Forums
... to advance the multiple aspects of the nation's cancer-fighting efforts. From increasing funding for cancer research to improving access to health care, these forums allow our country's top academic, medical and consumer minds to share their innovative work and discuss new paths forward. ...
New Report: Failure by Southeastern State Legislators on Tobacco Policies Leads to Higher Tobacco Use, Greater Cancer Burden
... result of tobacco use, according to the American Cancer Society (ACS). Given this, the state’s biggest opportunity to save lives and reduce health care costs would be increasing the price of tobacco products by $1.50 or more per pack of cigarettes. “North Carolina’s excise tax on ... increase to the tobacco tax would not only lower tobacco-use rates but also have the added benefit of saving the state millions of dollars in health care costs.” Based on data from the National Vital Statistics System from 2010 to 2014, the lung cancer mortality rate in the 12 ...
DonnaMarie Woodson, North Carolina
... been healthy, so I thought I could roll the dice and go without my regular screenings because of the cost. Boy, I was wrong. The Affordable Care Act saved my life. While in treatment, I vowed to advocate for other cancer patients and their families; In 2017, publishing my first Letter to the Editor opposing the repeal of the Affordable Care Act in the Charlotte Observer. A few months later, fate, in a call from Ray Riordan (ACS CAN Grassroots Manager 2017), set me off on the road ... ensures ongoing Cancer Research funding. As a new ACS CAN Black Volunteer Caucus (BVC) member, we are bringing more diversity into our fight for health equity and representation in our communities. We must irradicate Cancer and eliminate those three devastating words - “You Have Cancer.” ...
Expand Access to Biomarker Testing in Minnesota
... partners are working together to make sure more Minnesotans can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...
Expand Access to Biomarker Testing in New Jersey
... are working together to make sure more New Jersey residents can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment. Without action ... precision_medicine_and_biomarker_testing_fact_sheet_january_2025.pdf precision_medicine_and_biomarker_testing_fact_sheet_january_2025.pdf health_equity_in_biomarker_testing_and_targeted_therapy_december2024.pdf Videos: Video of ...
Idaho Policy Forum: Speaker Bios
... Inc. Dr. Whitney Jones is a Gastroenterologist, a former Clinical Professor of Medicine and current adjunct Professor in the School of Public Health and information services at the University of Louisville. He is a founding member and currently serves as Chair of the Kentucky Colon ... Bio Alliance of Medicine, an organization advocating for the growth of Idaho's biomedical ecosystem, creating a unified voice for biomedical and health research in Idaho. Krishna C. Alluri - MD Oncologist and Hematologist, St. Luke's Cancer Institute Dr. Krishna C. Alluri is board ... York. Before joining Oscar, he led various clinical and business development areas at EmblemHealth, Point-of Care Partners, MedImpact Health Care Systems, and Horizon Blue Cross Blue Shield of New Jersey. Early in his career, he worked at multiple ...
Idaho Cancer Action Day 2024
... In 2018, Idaho voters passed Medicaid expansion with 60% of the vote, sending a strong message that Idahoans wanted to see increased access to health care for their friends and neighbors. Expansion offers coverage to individuals earning up to $20,000 per year, and families of 4 earning up to ... cancer screenings, diagnostic testing, treatment services and follow-up care. Idaho legislators tried to override the will of the voters on health coverage expansion during the 2019 legislative session and it is important that we send a strong message that voters and constituents still ...
New York Biomarker Testing Campaign
... What is biomarker testing? Biomarker testing helps get the right treatment to the right patient at the right time. Progress in improving health outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to prevent, ... of a patient’s tissue, blood, or fluid biospecimen for the presence of a biomarker. Biomarker testing is increasingly important for cancer care – and for the treatment of other diseases. Thirty-seven of the 62 oncology drugs launched in the past five years require or recommend ... biomarker testing when medically appropriate. Improving access to biomarker testing and thereby access to targeted therapies will help reduce health disparities and improve outcomes for cancer patients. Expanding access to biomarker testing will also increase patient diversity in clinical ...
2020 ACS CAN Texas Cancer Policy Forum Series
... Network (ACS CAN) will host its seventh annual Texas Cancer Policy Forum series this fall, uniting key leaders and decision makers in business, health care, and government to consider the evolving needs of Texans accessing and affording equitable cancer care. Texas institutions are generating exciting new life-saving therapies and making advances in the fight against cancer, with significant ...
Type
- (-) Remove Basic page filter Basic page
Priority Issue
State
- New York (14) Apply New York filter
- California (6) Apply California filter
- Idaho (6) Apply Idaho filter
- New Jersey (6) Apply New Jersey filter
- West Virginia (5) Apply West Virginia filter
- Georgia (4) Apply Georgia filter
- Maine (4) Apply Maine filter
- Michigan (4) Apply Michigan filter
- Missouri (4) Apply Missouri filter
- North Carolina (4) Apply North Carolina filter
- South Dakota (4) Apply South Dakota filter
- Tennessee (4) Apply Tennessee filter
- Texas (4) Apply Texas filter
- District Of Columbia (3) Apply District Of Columbia filter
- Florida (3) Apply Florida filter
- Hawaii (3) Apply Hawaii filter
- Kentucky (3) Apply Kentucky filter
- Maryland (3) Apply Maryland filter
- Massachusetts (3) Apply Massachusetts filter
- Minnesota (3) Apply Minnesota filter